| Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine S Jangra, J De Vrieze, A Choi, R Rathnasinghe, G Laghlali, A Uvyn, ... Angewandte Chemie International Edition 60 (17), 9467-9473, 2021 | 51 | 2021 |
| Die another way: interplay between influenza A virus, inflammation and cell death G Laghlali, KE Lawlor, MD Tate Viruses 12 (4), 401, 2020 | 41 | 2020 |
| Sterilizing immunity against SARS-CoV-2 infection in mice by a single-shot and modified imidazoquinoline TLR7/8 agonist-adjuvanted recombinant spike protein vaccine S Jangra, J De Vrieze, A Choi, R Rathnasinghe, G Laghlali, A Uvyn, ... bioRxiv, 2020 | 7 | 2020 |
| RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine S Jangra, G Laghlali, A Choi, R Rathnasinghe, Y Chen, S Yildiz, ... Frontiers in immunology 13, 974016, 2022 | 6 | 2022 |
| Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice S Jangra, JJ Landers, G Laghlali, R Rathnasinghe, P Warang, SC Park, ... npj Vaccines 8 (1), 96, 2023 | 2 | 2023 |
| Utiliser le système CRISPR/Cas9 SAM (synergic activation mediator) pour identifier des facteurs de restriction antiviraux par criblage génomique B Dekeyzer, M Hoareau, G Laghlali médecine/sciences 34 (5), 401-403, 2018 | 2 | 2018 |
| Lipid nanoparticle encapsulation empowers poly (I: C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity A Lamoot, S Jangra, G Laghlali, P Warang, G Singh, LA Chang, SC Park, ... Small 20 (10), 2306892, 2024 | 1 | 2024 |
| Corrigendum: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike … S Jangra, J De Vrieze, A Choi, R Rathnasinghe, G Laghlali, A Uvyn, ... Angewandte Chemie (International ed. in English) 60 (31), 16741, 2021 | 1 | 2021 |
| Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection. G Laghlali, MD Tate Respirology 24 (10), 2019 | 1 | 2019 |
| Enhanced mucosal B-and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant. G Laghlali, MJ Wiest, D Karada, P Warang, JJ O'Konek, LA Chang, S Park, ... bioRxiv, 2024.03. 28.587260, 2024 | | 2024 |
| Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice. S Jangra, A Lamoot, G Singh, G Laghlali, Y Chen, T Ye, A García-Sastre, ... bioRxiv, 2024.01. 14.575599, 2024 | | 2024 |
| A rationally designed combined intranasal adjuvant drives robust and broad humoral, cellular, and mucosal immune responses to SARS-CoV-2 PT Wong, S Jangra, JJ Landers, G Laghlali, R Rathnasinghe, JJ O’Konek, ... The Journal of Immunology 210 (1_Supplement), 159.23-159.23, 2023 | | 2023 |
| A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice S Jangra, JJ Landers, G Laghlali, R Rathnasinghe, JJ O’Konek, ... Research Square, 2023 | | 2023 |
| RIG-I and TLR-7/8 agonists as combination adjuvant shape unique antibody and cellular vaccine responses to seasonal influenza vaccine M Schotsaert, S Jangra, G Laghlali, A Choi, R Rathnasinghe, Y Chen, ... | | 2022 |
| Berichtigung: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike … S Jangra, J De Vrieze, A Choi, R Rathnasinghe, G Laghlali, A Uvyn, ... Angewandte Chemie 133 (31), 2021 | | 2021 |
| CRISPR/Cas9 SAM (synergic activation mediator): a new strategy to screen for genome-encoded antiviral restriction factors B Dekeyzer, M Hoareau, G Laghlali Medecine Sciences: M/S 34 (5), 401-403, 2018 | | 2018 |
| Use the CRISPR/Cas9 SAM system (synergic activation mediator) to identify antiviral restriction factors by genome screening B Dekeyzer, M Hoareau, G Laghlali M S-MEDECINE SCIENCES 34 (5), 401-403, 2018 | | 2018 |
